Novel biomarker for glucocorticoids could help tailor treatments
Researchers have uncovered pathways involved in the body’s response to glucocorticoid treatments and identified a novel biomarker that could be used to monitor how these drugs work in patients, according to a clinical study published today in eLife. A more reliable indicator of an individual’s response to glucocorticoid drugs could be used to develop a…